Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis-Reference-Cited by-同舟云学术

Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis

Published:2022-12 Issue:12 Volume:28 Page:845.e1-845.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Takahashi Takuto^ORCID,Jaber Mutaz M.^ORCID,Al-Kofahi Mahmoud^ORCID,Weisdorf Daniel^ORCID,Brunstein Claudio,Bachanova Veronika,Brundage Richard C.,Jacobson Pamala A.,Kirstein Mark N.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference40 articles.

1. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation;McDonald;Blood,2003

2. Higher fludarabine and cyclophosphamide exposures lead to worse outcomes in reduced-intensity conditioning hematopoietic cell transplantation for adult hematologic malignancy;Takahashi;Transplant Cell Ther,2021

3. World Health Organization. World health statistics 2020: monitoring health for the SDGs, sustainable development goals. World Health Organization; 2020.

4. Prevalence of obesity and severe obesity among adults: United States, 2017-2018;Hales;NCHS Data Brief,2020

5. Effect of obesity on left ventricular function studied by radionuclide angiocardiography;Licata;Int J Obes,1991

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overweight and Obese Patients;The EBMT Handbook;2024

2. A Weighty Decision: Worth the wait?;Transplantation and Cellular Therapy;2023-01